Birds possess a specialized organ called the bursa of Fabricius that mammals do not have. It has long been thought that B ...

Researchers at the Icahn School of Medicine at Mount Sinai have identified the immune cell that acts as the architect and ...

Evaxion A/S (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ ...

Advancing a pipeline of in vivo CAR-T product candidates for oncology and immunology applications differentiated by CD7-targeted mRNA/LNP ...

Viral surveillance and predictive modeling are used to map mutational escape pathways and inform proactive antibody design against likely future variants rather than only current circulating strains.

Spero Therapeutics gets a Buy on the immunology pivot, FDA-approved Utebzi, and $105M royalty deal funding SP001. Learn more ...

Autoantibodies are central to the diagnosis, classification, and stratification of many autoimmune diseases, particularly ...

South Korean researchers have identified why immune checkpoint inhibitors fail to work against brain tumors such as ...

Financing supports Phase 2 development of SP001, Spero’s first immunology drug candidate, in-licensed from Innovent Biologics Transaction unlocks ...

Researchers at the Icahn School of Medicine at Mount Sinai have identified the immune cell that acts as the architect and coordinator of powerful immune hubs that form inside tumors and plays a key ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted priority review to the company’s supplemental ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 15, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of ...